Hacke, Werner

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine

Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage Research

Cited by 6,684

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet

Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage Research

Cited by 3,662

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Emberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet

Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage Research

Cited by 2,737

Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank

Grau, A. J., Weimar, C., Buggle, F., Heinrich, A., Goertler, M., Neumaier, S., Glahn, J., Brandt, T., Hacke, W., & Diener, H.-C. (2001) · Stroke

Acute Ischemic Stroke ManagementCerebrovascular and Carotid Artery Diseases

Cited by 998

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., & Topol, E. J. (2002) · The American Journal of Cardiology

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 409

Intraventricular Brain-Derived Neurotrophic Factor Reduces Infarct Size after Focal Cerebral Ischemia in Rats

Schäbitz, W.-R., Schwab, S., Spranger, M., & Hacke, W. (1997) · Journal of Cerebral Blood Flow & Metabolism

Neuroprotection in Cerebral IschemiaNerve injury and regeneration

Cited by 322

Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure

Lees, K. R., Bath, P. M. W., Schellinger, P. D., Kerr, D. M., Fulton, R., Hacke, W., Matchar, D., Sehra, R., & Toni, D. (2012) · Stroke

Acute Ischemic Stroke ManagementStroke Rehabilitation and Recovery

Cited by 242

Shift Analysis Versus Dichotomization of the Modified Rankin Scale Outcome Scores in the NINDS and ECASS-II Trials

Savitz, S. I., Lew, R., Bluhmki, E., Hacke, W., & Fisher, M. (2007) · Stroke

Acute Ischemic Stroke ManagementStatistical Methods in Clinical Trials

Cited by 119

Dichotomized Efficacy End Points and Global End-Point Analysis Applied to the ECASS Intention-to-Treat Data Set: Post Hoc Analysis of ECASS I

Hacke, W., Bluhmki, E., Steiner, T., Tatlisumak, T., Mahagne, M.-H., Sacchetti, M.-L., & Meier, D. (1998) · Stroke

Acute Ischemic Stroke ManagementStatistical Methods in Clinical Trials

Cited by 109

Bootstrap Statistics of ECASS II Data: Just Another post hoc Analysis of a Negative Stroke Trial?

Stingele, R., Bluhmki, E., & Hacke, W. (2001) · Cerebrovascular Diseases

Acute Ischemic Stroke ManagementStatistical Methods in Clinical Trials

Cited by 18